Blog

Effect Of Covid 19 On Patients Undergoing IVF Treatment

Regarding the impact of coronavirus disease 19 (COVID-19) infection on subsequent in vitro fertilisation (IVF) cycle attempts, there is no evidence in the literature. Patients' ovarian reserve or performance in their immediately next IVF cycle were unaffected by COVID-19 infection, with the exception of a lower percentage of top-quality embryos (TQEs).

We therefore suggest, to postpone IVF treatment for a least 3 months (duration of folliculogenesis and spermatogenesis) after recovering from COVID-19 infection, aiming to recruit healthy gametes that were not exposed to COVID-19 infection during their development.

For individuals who were attempting to get pregnant, the unexpected halt in infertility that followed the coronavirus disease-2019 (COVID-19) epidemic seemed like another loss. Because infertility might be categorised as a sickness, not all infertility care methods have to be viewed as voluntary. The distinction between necessary and unnecessary therapy is complicated. Therefore, frozen embryo transfer (FET) may be a potential answer for everyone who was ready to begin an IVF (in vitro fertilisation) round after years of attempting to conceive. FET has the capacity to separate conception from fertilisation. It means that an IVF cycle can be performed without a "embryo transfer" (ET), and the resulting embryo can be stored. After the COVID-19 epidemic has passed, the patient may get these frozen embryos. In this method, the patient can prevent the virus's harmful effects on the unborn child. A sudden pause in the fertility cycle may lead to a feeling of hopelessness among patients, with certain thoughts that “they will never be able to conceive or that their life will never be happy.” In fact, brief delays might not harm fertility. Pregnant women should be ready for a stress-free post-pandemic phase, as should their doctors. Thus, assisted reproductive technology (ART) may ensure that the virus spoils do not spoil their life expectations.